Press releaseGlobe Newswire
Insight Molecular Diagnostics
IMDX · NASDAQ
$3.03+$0.14 (+4.84%)TodayMarket closed ·
Prev close $2.89
Latest news
- Press releaseGlobe Newswire
iMDx to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum with KOL Discussion and Investor Meetings
- News
Transcript: Insight Molecular Q2 2026 Earnings Conference Call
- Press releaseGlobe Newswire
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
- Press releaseGlobe Newswire
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
- Press releaseGlobe Newswire
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
- Press releaseGlobe Newswire
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
- Press releaseGlobe Newswire
Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
- Press releaseGlobe Newswire
IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
- Press releaseGlobe Newswire
iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
- Press releaseGlobe Newswire
Favorable Head-to-Head Data on iMDx's GraftAssure with Competing NGS Assay Published in Clinical Chemistry
- Press releaseGlobe Newswire
iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
- News
Insight Molecular Q1 2026 Earnings Call Transcript
- Press releaseGlobe Newswire
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
- News
Earnings Scheduled For May 13, 2026
- Press releaseGlobe Newswire
iMDx to Release First Quarter 2026 Results on May 13, 2026
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- Press releaseGlobe Newswire
IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch
- News
Exploring Insight Molecular's Earnings Expectations
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.